OK, we realize we covered a lot of research last week on HIV pre-exposure prophylaxis (PrEP). We promise we're not falling into a rut! But our top story in this week's review of recently published peer-reviewed science on HIV is a valuable addition to the evolving conversation about how to discuss PrEP with patients -- just as our other highlighted studies are valuable to conversations around critical topics in HIV care.
This week's highlights include:
- An expert analysis on where the U.S. Center for Disease Control's official PrEP guidelines fall short -- and how they can be better.
- Support for partner notification services as a bulwark against onward HIV transmission among black men who have sex with men (MSM) and their partners.
- Findings that end-state liver disease is no longer the primary cause of death among Canadians coinfected with HIV and hepatitis C.
- New insights into correlates of lower HIV treatment adherence among people on methadone maintenance therapy. (Spoiler alert: Stigma doesn't help.)
If you're interested in PrEP or any of our other subjects of note this week, let's take a gander together at each of these new manuscripts. To beat HIV, you have to follow the science!